- Telehealth visits
Gabriel Salinas Cisneros, MD
He | Him | HisPediatric Hematology-Oncology- Telehealth visits
Gabriel Salinas Cisneros, MD
He | Him | HisPediatric Hematology-Oncology- Telehealth visits
On this page
About me
Dr. Gabriel Salinas Cisneros is a pediatric hematologist-oncologist who cares for patients undergoing bone marrow transplants. He has a special interest in finding ways to prevent complications from the procedure.
Salinas Cisneros' research focuses on sinusoidal obstructive syndrome, a bone marrow transplant complication in which the liver's small blood vessels become blocked. He is a member of the Latin American Bone Marrow Transplantation Group.
Salinas Cisneros earned his medical degree at Universidad de San Martín de Porres in Peru. He completed a residency in pediatrics at Nicklaus Children's Hospital, followed by a fellowship in pediatric hematology and oncology at Children's National Hospital and a fellowship in pediatric bone marrow transplantation at UCSF.
Education & training
Board certification
- Pediatric Hematology-Oncology, American Board of Pediatrics
- General Pediatrics, American Board of Pediatrics
Fellowship
- Bone Marrow Transplant, UCSF School of Medicine -GME
- Ped. Hema/Oncology, Children's National Hospital
Residency
- Pediatrics, Nicklaus Children's Hospital
Degree
- MD, Universidad San Martin de Porres
Academic Title
- Health Sciences Clinical Professor
My expertise
Specialties
- Pediatric Hematology-Oncology
Treatments
- Blood and Bone Marrow Transplant
Locations
My research
Clinical trials
TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT PatientsOpens in a new window
Recruiting
Participants will be assessed for lung injury at 24 months after HSCT
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.